When to Use MyPath Melanoma: Solving Ambiguity in Diagnosing Pigmented Lesions

Pitfalls in the diagnosis of pigmented lesionsПодробнее

Cases with Castle: Resolving diagnostic ambiguity using GEP testing - Dr. Clay CockerellПодробнее

Utilizing Melanoma Molecular Tests for Diagnosis in Skin CancerПодробнее

When to Use MyPath Melanoma: Dr. Neil Fernandes on Managing Ambiguous Skin LesionsПодробнее

Cases with Castle Biosciences - Barry White, M.D.Подробнее

When to Use MyPath Melanoma: Dr. Shannon Trotter on Diagnosing Ambiguous Skin LesionsПодробнее

Diagnosis of Pigmented LesionsПодробнее

Confirming Difficult Diagnoses in Melanocytic Lesions with MyPath MelanomaПодробнее

Understanding Your Pathology ReportПодробнее

Understanding Your Pathology Report - How Do We Use it to Determine What Treatment is Best?Подробнее

Dr. Clarke on the myPath Test for MelanomaПодробнее

Episode 10: Pigmented lesionsПодробнее

How to use dermatoscopic decision algorithms to assess pigmented skin | Prof Cliff RosendahlПодробнее

How MyPath Melanoma Results Guide Treatment and Surgical DecisionsПодробнее

Utility of Genetic Expression Profiling in Melanocytic LesionsПодробнее

The Role That Pathology Plays in Melanoma CareПодробнее

Palmetto GBA Open Meeting August 1, 2022Подробнее